Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
40.44 USD | -3.69% | -3.02% | -33.04% |
May. 07 | MoonLake Immunotherapeutics Q1 Net Loss Widens | MT |
May. 07 | MoonLake Immunotherapeutics Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.04% | 2.64B | |
+16.82% | 121B | |
+13.18% | 107B | |
-5.49% | 24.82B | |
+1.69% | 22.48B | |
-10.09% | 18.32B | |
-40.52% | 16.33B | |
-14.13% | 15.31B | |
+1.86% | 14.08B | |
+24.35% | 11.74B |
- Stock Market
- Equities
- MLTX Stock
- News MoonLake Immunotherapeutics
- Wedbush Starts MoonLake Immunotherapeutics at Outperform With Price Target of $33